Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ting Gui, Huimin Bai, Jianfang Zeng, Zhaoji Zhong, Dongyan Cao, Quancai Cui, Jie Chen, Jiaxin Yang & Keng Shen. (2014) Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins. OncoTargets and Therapy 7, pages 1705-1716.
Read now
Read now
Daphne S. Cabianca, Valentina Casa & Davide Gabellini. (2012) A novel molecular mechanism in human genetic disease. RNA Biology 9:10, pages 1211-1217.
Read now
Read now
Articles from other publishers (14)
Zuoyun Wang, Zhaoyuan Fang, Gaobin Chen, Bo Liu, Jinjin Xu, Fei Li, Fuming Li, Hongyan Liu, Haoen Zhang, Yihua Sun, Gang Tian, Haiquan Chen, Guoliang Xu, Lei Zhang, Liang Hu & Hongbin Ji. (2021) Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma through the Wnt/β-catenin pathway. Neoplasia 23:2, pages 222-233.
Crossref
Crossref
Arthur ZimmermannArthur Zimmermann. 2017. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
3029
3040
.
Soo Hee Kim, Woo Ick Yang, Yoo Hong Min, Young Hyeh Ko & Sun Och Yoon. (2015) The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications. Tumor Biology 37:2, pages 2037-2047.
Crossref
Crossref
Arthur ZimmermannArthur Zimmermann. 2016. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
1
13
.
Chao Huang & Bin Wen. (2015) “Identification Card”: Sites on Histone Modification of Cancer Cell. Chinese Medical Sciences Journal 30:4, pages 203-209.
Crossref
Crossref
Francesco Neri, Danny Incarnato, Anna Krepelova, Daniela Dettori, Stefania Rapelli, Mara Maldotti, Caterina Parlato, Francesca Anselmi, Federico Galvagni & Salvatore Oliviero. (2015) TET1 is controlled by pluripotency-associated factors in ESCs and downmodulated by PRC2 in differentiated cells and tissues. Nucleic Acids Research 43:14, pages 6814-6826.
Crossref
Crossref
Yan-Long Liu, Xu Gao, Yang Jiang, Gan Zhang, Zi-Cheng Sun, Bin-Bin Cui & Yan-Mei Yang. (2014) Expression and clinicopathological significance of EED, SUZ12 and EZH2 mRNA in colorectal cancer. Journal of Cancer Research and Clinical Oncology 141:4, pages 661-669.
Crossref
Crossref
Hajime Abe, Takashi Ogawa, Liyun Wang, Masayuki Kimura, Takeshi Tanaka, Reiko Morita, Toshinori Yoshida & Makoto Shibutani. (2014) Promoter-region hypermethylation and expression downregulation of Yy1 (Yin yang 1) in preneoplastic liver lesions in a thioacetamide rat hepatocarcinogenesis model. Toxicology and Applied Pharmacology 280:3, pages 467-474.
Crossref
Crossref
Ji Tao, Yan-Long Liu, Gan Zhang, Yu-Yan Ma, Bin-Bin Cui & Yan-Mei Yang. (2014) Expression and clinicopathological significance of Mel-18 mRNA in colorectal cancer. Tumor Biology 35:10, pages 9619-9625.
Crossref
Crossref
Ana-Maria Dragoi, Rachel Swiss, Beile Gao & Hervé Agaisse. (2014) Novel Strategies to Enforce an Epithelial Phenotype in Mesenchymal Cells. Cancer Research 74:14, pages 3659-3672.
Crossref
Crossref
Sang Yun Ha & Seok-Hyung Kim. (2012) Co-expression of Bmi1 and EZH2 as an independent poor prognostic factor in esophageal squamous cell carcinoma. Pathology - Research and Practice 208:8, pages 462-469.
Crossref
Crossref
Mukesh Verma. (2012) Cancer Control and Prevention by Nutrition and Epigenetic Approaches. Antioxidants & Redox Signaling 17:2, pages 355-364.
Crossref
Crossref
Amanda Ewart Toland. 2012. Patho-Epigenetics of Disease. Patho-Epigenetics of Disease
91
122
.
Thomas Prates Ong, Fernando Salvador Moreno & Sharon Ann Ross. (2011) Targeting the Epigenome with Bioactive Food Components for Cancer Prevention. Journal of Nutrigenetics and Nutrigenomics 4:5, pages 275-292.
Crossref
Crossref